These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 25662350)
1. Comment on severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody. Arrambide G; Tur C; Montalban X Mult Scler; 2015 Apr; 21(5):660-1. PubMed ID: 25662350 [No Abstract] [Full Text] [Related]
2. Severe demyelination but no astrocytopathy in clinically definite neuromyelitis optica with anti-myelin-oligodendrocyte glycoprotein antibody. Ikeda K; Kiyota N; Kuroda H; Sato DK; Nishiyama S; Takahashi T; Misu T; Nakashima I; Fujihara K; Aoki M Mult Scler; 2015 Apr; 21(5):656-9. PubMed ID: 25257613 [TBL] [Abstract][Full Text] [Related]
4. Inflammatory demyelination without astrocyte loss in MOG antibody-positive NMOSD. Wang JJ; Jaunmuktane Z; Mummery C; Brandner S; Leary S; Trip SA Neurology; 2016 Jul; 87(2):229-31. PubMed ID: 27306633 [No Abstract] [Full Text] [Related]
5. Connexins in neuromyelitis optica: a link between astrocytopathy and demyelination. Richard C; Ruiz A; Cavagna S; Bigotte M; Vukusic S; Masaki K; Suenaga T; Kira JI; Giraudon P; Marignier R Brain; 2020 Sep; 143(9):2721-2732. PubMed ID: 32889550 [TBL] [Abstract][Full Text] [Related]
6. Intravenous Immunoglobulin Therapy in a Patient With Anti-Myelin Oligodendrocyte Glycoprotein-Seropositive Neuromyelitis Optica. Domingo-Santos Á; Sepúlveda M; Matarazzo M; Calleja-Castaño P; Ramos-González A; Saiz A; Benito-León J Clin Neuropharmacol; 2016; 39(6):332-334. PubMed ID: 27454390 [No Abstract] [Full Text] [Related]
7. [Animal model of neuromyelitis optica]. Okuno T; Kinoshita M; Nakatsuji Y; Mochizuki H Nihon Rinsho; 2015 Sep; 73 Suppl 7():81-9. PubMed ID: 26480684 [No Abstract] [Full Text] [Related]
9. Myelin oligodendrocyte glycoprotein antibody-associated demyelination: comparison between onset phenotypes. Zhou Y; Jia X; Yang H; Chen C; Sun X; Peng L; Kermode AG; Qiu W Eur J Neurol; 2019 Jan; 26(1):175-183. PubMed ID: 30153357 [TBL] [Abstract][Full Text] [Related]
10. Neuromyelitis Optica Spectrum Disorders. Akaishi T; Nakashima I; Sato DK; Takahashi T; Fujihara K Neuroimaging Clin N Am; 2017 May; 27(2):251-265. PubMed ID: 28391784 [TBL] [Abstract][Full Text] [Related]
11. Clinical and MRI phenotype of children with MOG antibodies. Fernandez-Carbonell C; Vargas-Lowy D; Musallam A; Healy B; McLaughlin K; Wucherpfennig KW; Chitnis T Mult Scler; 2016 Feb; 22(2):174-84. PubMed ID: 26041801 [TBL] [Abstract][Full Text] [Related]
12. Clinical features and long-term outcome of a group of Japanese children with inflammatory central nervous system disorders and seropositivity to myelin-oligodendrocyte glycoprotein antibodies. Hino-Fukuyo N; Haginoya K; Nakashima I; Sato DK; Takahashi T; Misu T; Fujihara K; Hirose M; Kakisaka Y; Uematsu M; Kobayashi T; Kure S Brain Dev; 2015 Oct; 37(9):849-52. PubMed ID: 25748628 [TBL] [Abstract][Full Text] [Related]
13. Myelin oligodendrocyte glycoprotein antibodies: How clinically useful are they? Reindl M; Jarius S; Rostasy K; Berger T Curr Opin Neurol; 2017 Jun; 30(3):295-301. PubMed ID: 28248700 [TBL] [Abstract][Full Text] [Related]
14. CD8-Positive T-Cell Leukoencephalitis With Astrocytopathy Clinically Presenting as Neuromyelitis Optica. Thomas DL; Manners J; Marker D; Mettenburg J; Murdoch G; Stevens B; Wang G; Wiley C J Neuropathol Exp Neurol; 2017 May; 76(5):347-357. PubMed ID: 28340257 [TBL] [Abstract][Full Text] [Related]
15. Neuromyelitis optica: a demyelinating disease characterized by acute destruction and regeneration of perivascular astrocytes. Parratt JD; Prineas JW Mult Scler; 2010 Oct; 16(10):1156-72. PubMed ID: 20823059 [TBL] [Abstract][Full Text] [Related]
16. Persisting myelin oligodendrocyte glycoprotein antibodies in aquaporin-4 antibody negative pediatric neuromyelitis optica. Rostásy K; Mader S; Hennes EM; Schanda K; Gredler V; Guenther A; Blaschek A; Korenke C; Pritsch M; Pohl D; Maier O; Kuchukhidze G; Brunner-Krainz M; Berger T; Reindl M Mult Scler; 2013 Jul; 19(8):1052-9. PubMed ID: 23257621 [TBL] [Abstract][Full Text] [Related]
17. [Connexin astrocytopathy and novel therapeutic strategy targeting connexin hemichannels in demyelinating disease]. Masaki K Rinsho Shinkeigaku; 2012; 52(11):1354-6. PubMed ID: 23196616 [TBL] [Abstract][Full Text] [Related]
18. The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives. Jasiak-Zatonska M; Kalinowska-Lyszczarz A; Michalak S; Kozubski W Int J Mol Sci; 2016 Mar; 17(3):273. PubMed ID: 26950113 [TBL] [Abstract][Full Text] [Related]